Helix BioMedix, Inc. (HXBM)
USD 7.18
(0.0%)
USD 7.18
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -984.05 Thousand USD | 8.78% |
| 2022 | -1.07 Million USD | 0.0% |
| 2011 | -2.4 Million USD | 18.67% |
| 2010 | -2.95 Million USD | 8.13% |
| 2009 | -3.21 Million USD | 9.21% |
| 2008 | -3.54 Million USD | -0.73% |
| 2007 | -3.51 Million USD | 9.82% |
| 2006 | -3.9 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 FY | -984.05 Thousand USD | 8.78% |
| 2022 FY | -1.07 Million USD | 0.0% |
| 2011 FY | -2.4 Million USD | 18.67% |
| 2010 FY | -2.95 Million USD | 8.13% |
| 2009 FY | -3.21 Million USD | 9.21% |
| 2008 FY | -3.54 Million USD | -0.73% |
| 2007 FY | -3.51 Million USD | 9.82% |
| 2006 FY | -3.9 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1.33 Million USD | 26.312% |
| Arch Therapeutics, Inc. | -5.04 Million USD | 80.492% |
| Evofem Biosciences, Inc. | -17.84 Million USD | 94.486% |
| Nascent Biotech, Inc. | -2.22 Million USD | 55.87% |
| Rebus Holdings, Inc. | -664 Thousand USD | -48.201% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 101.202% |
| Qrons Inc. | -643.67 Thousand USD | -52.88% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -152.6% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | 98.227% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -136.848% |
| Skye Bioscience, Inc. | -13.67 Million USD | 92.802% |
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | 98.629% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 120.022% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -275.986% |
| SQZ Biotechnologies Company | -75.82 Million USD | 98.702% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | 65.478% |
| Propanc Biopharma, Inc. | -1.53 Million USD | 35.936% |
| Mesoblast Limited | -84.14 Million USD | 98.831% |
| Marizyme, Inc. | -34.08 Million USD | 97.113% |
| Genus plc | 6.4 Million USD | 115.376% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 110.101% |
| Pharming Group N.V. | -4.87 Million USD | 79.833% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | 50.462% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -5.655% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | 88.215% |
| ContraFect Corporation | -56.88 Million USD | 98.27% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | 78.395% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | 29.81% |
| IMV Inc. | -38.67 Million USD | 97.455% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | 64.227% |
| MultiCell Technologies, Inc. | -722.81 USD | -136042.693% |
| ONE Bio Corp. | 13.68 Million USD | 107.193% |
| Accustem Sciences Inc. | -3.74 Million USD | 73.734% |
| RVL Pharmaceuticals plc | -58.99 Million USD | 98.332% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -483.06 Thousand USD | -103.712% |
| Q BioMed Inc. | -3.44 Million USD | 71.44% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 127.798% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | 62.548% |
| Biomind Labs Inc. | -1 Million USD | 2.531% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | 98.21% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | 66.082% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | 85.198% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | 47.218% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -3185.433% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 93.799% |
| Curative Biotechnology, Inc. | -1.93 Million USD | 49.082% |
| GB Sciences, Inc. | -1.42 Million USD | 30.725% |
| Alpha Cognition Inc. | -9.7 Million USD | 89.861% |
| HST Global, Inc. | -140.9 Thousand USD | -598.371% |
| CSL Limited | 3.7 Billion USD | 100.027% |
| Wesana Health Holdings Inc. | -1.12 Million USD | 12.521% |
| Halberd Corporation | -75.05 Thousand USD | -1211.197% |
| Enzolytics Inc. | -2.14 Million USD | 54.205% |
| Agentix Corp. | -1.37 Million USD | 28.263% |
| Resverlogix Corp. | -12.74 Million USD | 92.281% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | 68.94% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -425.04 Million USD | 99.768% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | 5.742% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | 66.293% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | 37.693% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | 71.1% |
| AVAX Technologies, Inc. | 6.69 Million USD | 114.703% |
| Zenith Capital Corp. | -8.94 Million USD | 88.996% |
| Genscript Biotech Corporation | -415.79 Million USD | 99.763% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -5548.66% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | 59.922% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -473.76% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | 50.914% |
| Kadimastem Ltd | -3.04 Million USD | 67.632% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.25 Million USD | 21.652% |
| BioStem Technologies, Inc. | -7.77 Million USD | 87.35% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -442.223% |
| LadRx Corporation | -3.82 Million USD | 74.264% |
| Cell Source, Inc. | -4.32 Million USD | 77.249% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -43.25% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -43.25% |
| NovAccess Global Inc. | -2.46 Million USD | 60.107% |
| Affymax, Inc. | -15.04 Million USD | 93.46% |
| Itoco Inc. | -919.14 Thousand USD | -7.062% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | 76.783% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | 12.06% |
| Mobile Lads Corp. | -554.55 Thousand USD | -77.451% |
| CytoDyn Inc. | -18.05 Million USD | 94.551% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -3809.627% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -347.138% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -74.254% |
| SYBLEU INC | -149.18 Thousand USD | -559.641% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | 45.822% |
| International Stem Cell Corporation | -663 Thousand USD | -48.424% |
| Bioxytran, Inc. | -3.82 Million USD | 74.24% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -1769.402% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -4738.019% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | 97.287% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | 39.181% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -33.733% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | 68.369% |
| Neutra Corp. | -229.48 Thousand USD | -328.807% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | 94.389% |
| PureTech Health plc | -146.19 Million USD | 99.327% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | 95.421% |
| IXICO plc | -1.43 Million USD | 31.52% |
| IntelGenx Technologies Corp. | -9.49 Million USD | 89.632% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 99.192% |
| CSL Limited | 3.81 Billion USD | 100.026% |
| Cellectis S.A. | -108.85 Million USD | 99.096% |